Successful rechallenge of bevacizumab after grade 4 bevacizumab induced hypertension in a case of carcinoma ovary, is rechallenging an option? - A Rare case report | Zendy

AI Assistant Blog Pricing

Successful rechallenge of bevacizumab after grade 4 bevacizumab induced hypertension in a case of carcinoma ovary, is rechallenging an option? - A Rare case report

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.